ATE459597T1 - Propanolaminomethyltetraline, ihre herstellung und pharmazeutische zusammenstellungen - Google Patents

Propanolaminomethyltetraline, ihre herstellung und pharmazeutische zusammenstellungen

Info

Publication number
ATE459597T1
ATE459597T1 AT02799764T AT02799764T ATE459597T1 AT E459597 T1 ATE459597 T1 AT E459597T1 AT 02799764 T AT02799764 T AT 02799764T AT 02799764 T AT02799764 T AT 02799764T AT E459597 T1 ATE459597 T1 AT E459597T1
Authority
AT
Austria
Prior art keywords
sub
alk
group
phenyl
alkoxy
Prior art date
Application number
AT02799764T
Other languages
English (en)
Inventor
Laura Barzaghi
Roberto Cecchi
Nunzia Viviani
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of ATE459597T1 publication Critical patent/ATE459597T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Pregnancy & Childbirth (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02799764T 2001-12-05 2002-12-02 Propanolaminomethyltetraline, ihre herstellung und pharmazeutische zusammenstellungen ATE459597T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0115684A FR2833010B1 (fr) 2001-12-05 2001-12-05 Propanolaminomethyltetralines, leur preparation et compositions pharmaceutiques les contenant
PCT/FR2002/004129 WO2003048117A2 (fr) 2001-12-05 2002-12-02 Propanolaminomethyltetralines, leur preparation et composition pharmaceutiques en contenant

Publications (1)

Publication Number Publication Date
ATE459597T1 true ATE459597T1 (de) 2010-03-15

Family

ID=8870112

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02799764T ATE459597T1 (de) 2001-12-05 2002-12-02 Propanolaminomethyltetraline, ihre herstellung und pharmazeutische zusammenstellungen

Country Status (8)

Country Link
US (1) US7115780B2 (de)
EP (1) EP1453796B1 (de)
JP (1) JP4852230B2 (de)
AT (1) ATE459597T1 (de)
AU (1) AU2002364411A1 (de)
DE (1) DE60235572D1 (de)
FR (1) FR2833010B1 (de)
WO (1) WO2003048117A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130080932A1 (en) 2011-09-27 2013-03-28 Sanjiv Sirpal Secondary single screen mode activation through user interface toggle

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004028A (en) * 1975-08-06 1977-01-18 Smithkline Corporation Phenoxypropanolamines
US5194450A (en) * 1988-04-20 1993-03-16 Burroughs Wellcome Co. Anti-hypertensive sulfonanilides
FR2640969B1 (de) * 1988-12-23 1991-11-22 Midy Spa
US5254595A (en) 1988-12-23 1993-10-19 Elf Sanofi Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them
US5254598A (en) * 1991-12-09 1993-10-19 Southwest Research Institute Biodegradable composition and products
EP1070046A1 (de) 1998-04-06 2001-01-24 Fujisawa Pharmaceutical Co., Ltd. Propanolaminderivate
FR2809725B1 (fr) * 2000-06-06 2004-05-07 Sanofi Synthelabo Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant

Also Published As

Publication number Publication date
AU2002364411A1 (en) 2003-06-17
FR2833010A1 (fr) 2003-06-06
US20050054641A1 (en) 2005-03-10
FR2833010B1 (fr) 2004-02-20
JP2005511687A (ja) 2005-04-28
WO2003048117A3 (fr) 2003-12-11
EP1453796B1 (de) 2010-03-03
EP1453796A2 (de) 2004-09-08
JP4852230B2 (ja) 2012-01-11
WO2003048117A2 (fr) 2003-06-12
DE60235572D1 (de) 2010-04-15
US7115780B2 (en) 2006-10-03

Similar Documents

Publication Publication Date Title
AR045255A1 (es) Derivados de 1,2 benzodiazol
EA200802389A1 (ru) Азиридинилэпотилоновые соединения
ATE356117T1 (de) Derivate des n-((chinolinyl)oxy)-phenyl)- harnstoffs und des n-((chinazolinyl)oxy)-phenyl)- harnstoffs mit antitumor aktivität
AR016307A1 (es) Imidazopirimidinas e imidazopiridinas, metodo para el tratamiento de afecciones neurologicas, y composicion farmaceutica.
PE20090042A1 (es) Analogos de ciclopamina
DK1451155T3 (da) Sammensætninger, metoder og kits i forbindelse med luminescerende forbindelser
DK1767535T3 (da) Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse
DE60033964D1 (de) Phenoxypropanolamin-derivate, ihre herstellung und therapeutische verwendung
ATE239708T1 (de) Huperzin-derivate, ihre herstellung und ihre verwendung
BRPI0518068A (pt) composto ou um éster ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor seletivo de aurora a, agente anti-tumor, e, preparação combinada
AR041246A1 (es) Derivados de piridina; un procedimiento de preparacion de los mismos y composicion farmaceutica que los contiene
DK0742203T3 (da) Vitamin D-forbindelser og fremgangsmåde til fremstilling deraf
ATE503746T1 (de) Neue imidazolidinderivate
EA200100090A2 (ru) Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
DK0790248T3 (da) 3-Aza-piperidon-(tetrahydropyrimidin-2-on)- og 3-oxa-piperidon-(1,3-oxazin-2-on)-derivater, deres fremstilling og deres anvendelse som tachykinin/neurokinin-antagonister
ATE374748T1 (de) Phenylcyclohexylpropanolaminderivate, deren herstellung und therapeutsche anwendung
WO2006021655A8 (fr) Dérivés doxopiperidine, leur préparation et leur application en thérapeutique
DE60235365D1 (de) Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
MA33103B1 (fr) Derives de 6-(6-substitue-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles et 5-fluoro-benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met
DE60235572D1 (de) Propanolaminomethyltetraline, ihre herstellung und pharmazeutische zusammenstellungen
EA200501136A1 (ru) Триазольные соединения, полезные в терапии
ES2099180T3 (es) Derivados del benzopirano y procedimientos para su preparacion.
NO20033049L (no) Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1-metylpiperidin
NO20064336L (no) Benzopyranforbindelser
ATE336487T1 (de) Benzoesaüre derivate und deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties